China Universal Asset Management »

Immunovant shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $903k 28k 32.32
2023-12-31 $705k 17k 42.13
2023-09-30 $129k 3.4k 38.39
2023-06-30 $32k 1.7k 18.72
2023-03-31 $27k 1.8k 15.31
2022-12-31 $23k 1.3k 17.53
2022-09-30 $6.0k 1.1k 5.49

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Susquehanna International
Ikarian Capital

View all funds holding Immunovant